Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...
Once shortages ease, companies peddling these alternatives could face a crackdown. Last week, the Food and Drug ...
Reuters on MSN2d
Analysis-Americans hungry for weight-loss drugs grapple with supply and insurance hurdlesAmericans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk's weight-loss and diabetes drugs but cannot ...
Lilly last week reported a rare $1.5 billion sales miss for its injectable obesity drug Zepbound and diabetes medicine Mounjaro combined, raising concerns among investors that demand might be cooling ...
Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...
Only time will tell if GLP-1 drugs are headed for those fates, Palakodeti says. Novo Nordisk, the drug company that makes ...
Most of us are aware of the concept of drug side effects, which can be either negative or positive. The goal of any drug ...
As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback